Azstarys

Chemical Nameserdexmethylphenidate and dexmethylphenidate
Dosage FormCapsule (oral; serdexmethylphenidate/dexmethylphenidate: 26.1 mg/5.2 mg, 39.2 mg/7.8 mg, 52.3 mg/10.4 mg)
Drug ClassStimulants
SystemNervous
CompanyCorium
Approval Year2021

Indication

  • For the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older
Last updated on 5/2/2022

More on this drug: Clinical Trials

Document TitleYearSource
Azstarys (serdexmethylphenidate and dexmethylphenidate) Prescribing Information.2021Corium, Inc. Grand Rapids, MI

Have we missed a study, or would you like to comment on a study?